LexisNexis® Legal News Podcast for April 30, 2010

A securities fraud class action against Boston Scientific is dismissed, and, AstraZeneca finalizes a $520 million settlement over Seroquel off-label marketing claims. Hear these and other stories from LexisNexis® Mealey’s Publications. Copyright© 2010 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.

No related posts.

FREE Case Review

Defective DrugsAdverse reactions to medications on the market.

Personal InjuryPersonal injuries resulting from negligence may lead to significant medical expenses.

Toxic ExposureDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

DiseasesDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

Financial FraudsUnethical actions by large corporations may cause financial hardship.

Medical MalpracticeMedical errors or negligent health care resulting in injury or death.

LexisNexis® Legal News Podcast for April 30, 2010

FREE Case Review

Trending Topics